TargetEyes absent homolog 3 [223-510](Mus musculus (Mouse))
Cincinnati Childrens Hospital Medical Center
US Patent
Cincinnati Childrens Hospital Medical Center
US Patent
Affinity DataIC50: 1.01E+4nMAssay Description:The compounds were then tested using full-length human recombinant, purified EYA3 and pNPP as a substrate. Compounds were dissolved in DMSO and dilut...More data for this Ligand-Target Pair
TargetEyes absent homolog 3 [223-510](Mus musculus (Mouse))
Cincinnati Childrens Hospital Medical Center
US Patent
Cincinnati Childrens Hospital Medical Center
US Patent
Affinity DataIC50: 1.10E+4nMAssay Description:The compounds were then tested using full-length human recombinant, purified EYA3 and pNPP as a substrate. Compounds were dissolved in DMSO and dilut...More data for this Ligand-Target Pair
TargetEyes absent homolog 3 [223-510](Mus musculus (Mouse))
Cincinnati Childrens Hospital Medical Center
US Patent
Cincinnati Childrens Hospital Medical Center
US Patent
Affinity DataIC50: 1.92E+4nMAssay Description:The compounds were then tested using full-length human recombinant, purified EYA3 and pNPP as a substrate. Compounds were dissolved in DMSO and dilut...More data for this Ligand-Target Pair